Noriko Shimasaki
- Immunology top 1%
- Immune Cell Function and Interaction 16
- Oncology top 1%
- CAR-T cell therapy research 16
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 5
-
- Acute Lymphoblastic Leukemia research 5
-
- Infection Control and Ventilation 7
-
- Respiratory viral infections research 7
- Influenza Virus Research Studies 5
-
- Virus-based gene therapy research 5
- Co-authors
- Dario CampanaAmit JainHiroyuki FujisakiYu-Hsiang ChangTimothy LockeyChihaya ImaiWing LeungPaul W. Eldridge
- Cited by
- ImmunologyOncologyHematology
- Partner nations
- JapanSingaporeUnited States
In The Last Decade
Noriko Shimasaki
49 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Immunology 2.0k
- Oncology 1.9k
- Hematology 392
- Public Health, Environmental and Occupational Health 339
- Pediatrics, Perinatology and Child Health 227
Countries citing papers authored by Noriko Shimasaki
This map shows the geographic impact of Noriko Shimasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Shimasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Shimasaki more than expected).
Fields of papers citing papers by Noriko Shimasaki
This network shows the impact of papers produced by Noriko Shimasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Shimasaki. The network helps show where Noriko Shimasaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noriko Shimasaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 26 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 22 | |
| 6 | NK cells for cancer immunotherapybreakdown → | 2020 | 879 |
| 7 | 2020 | 3 | |
| 8 | 2019 | 7 | |
| 9 | 2019 | 22 | |
| 10 | 2016 | 171 | |
| 11 | 2016 | 5 | |
| 12 | 2013 | 272 | |
| 13 | 2012 | 141 | |
| 14 | 2012 | 18 | |
| 15 | 2011 | 50 | |
| 16 | 2010 | 193 | |
| 17 | 2009 | 471 | |
| 18 | 2007 | 52 | |
| 19 | 2004 | 6 | |
| 20 | 2004 | 32 |
About Noriko Shimasaki
Noriko Shimasaki is a scholar working on Immunology, Oncology and Hematology, having authored 51 papers that have together received 3.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (16 papers), Infection Control and Ventilation (7 papers), Respiratory viral infections research (7 papers), Influenza Virus Research Studies (5 papers), Virus-based gene therapy research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Immunology (2.0k citations), Oncology (1.9k citations) and Hematology (392 citations). Noriko Shimasaki has collaborated with scholars based in Japan, Singapore and United States. Frequent co-authors include Dario Campana, Amit Jain, Hiroyuki Fujisaki, Yu-Hsiang Chang, Timothy Lockey, Chihaya Imai, Wing Leung, Paul W. Eldridge, Elaine Coustan‐Smith and Takahiro Kamiya. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.